Chemesis International Inc., together with its subsidiaries, cultivates, manufactures, distributes, and retails cannabis products in California, Puerto Rico, and Colombia. It offers various types of extractions, formulations, and products specializing in BHO extraction, alcohol extraction, and CO2 extraction. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.
Research context
Chemesis International Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
Chemesis International Inc is currently in a long term downtrend where the price is trading 24.5% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
Chemesis International Inc's total revenue sank by 100.0% to $0 since the same quarter in the previous year.
Its net income has increased by 38.0% to $-10M since the same quarter in the previous year.
Finally, its free cash flow grew by 170.4% to $3M since the same quarter in the previous year.
Based on the above factors, Chemesis International Inc gets an overall score of 3/5.